The Alibaba Health-backed medical data technology and services provider has chosen the US for its planned initial public offering.

The cancer and autoimmune disease drug developer completed a Legend Star-backed series D round led by Mirae Asset Financial Group.

Cold Spring Harbor Laboratory will work with Autobahn Labs to propel more early-stage discovery programmes into spinouts.

The pregnancy biomarker test provider plans to float on the Nasdaq Global Market having raised $220m in funding from investors including LabCorp and Anthem.

Ohio State University has again thrown its weight behind Rev1 Ventures, whose latest fund also attracted University of Dayton and multiple corporates.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Keio spinout Heartseed has added $37m to its coffers thanks to the university's Innovation Initiative and UTokyo Innovation Platform.

Access Industries has led a financing round for the mental health services provider at a $1.2bn valuation, with the funding set to support an expansion in its services.

Mayo Clinic and Alexandria Venture Investments contributed to a $55m extension that boosted the molecular drug developer's overall funding to $143m.

A range of new and existing backers have added $45m to ViaCyte’s series D round, which now stands at more than $115m.